Volume | 176,917 |
|
|||||
News | - | ||||||
Day High | 14.2899 | Low High |
|||||
Day Low | 13.91 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
NeoGenomics Inc | NEO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
14.12 | 13.91 | 14.2899 | 14.16 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3,207 | 176,917 | $ 14.05 | $ 2,485,548 | - | 11.03 - 21.22 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:39:04 | 10 | $ 13.93 | USD |
NeoGenomics (NEO) Options Flow Summary
NeoGenomics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.78B | 127.61M | - | 591.64M | -87.97M | -0.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NeoGenomics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NEO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 13.97 | 14.47 | 13.34 | 13.72 | 778,912 | -0.04 | -0.29% |
1 Month | 15.38 | 15.91 | 13.34 | 14.44 | 677,380 | -1.45 | -9.43% |
3 Months | 15.42 | 17.49 | 13.34 | 15.15 | 905,404 | -1.49 | -9.66% |
6 Months | 13.76 | 21.22 | 13.33 | 16.31 | 984,008 | 0.17 | 1.24% |
1 Year | 16.04 | 21.22 | 11.03 | 15.86 | 933,321 | -2.11 | -13.15% |
3 Years | 50.93 | 54.74 | 6.00 | 18.17 | 1,177,848 | -37.00 | -72.65% |
5 Years | 20.16 | 61.57 | 6.00 | 23.12 | 1,049,458 | -6.23 | -30.90% |
NeoGenomics Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services. |